Recent Updates — COCHW

Envoy Medical stockholders approved an amendment to the Certificate of Incorporation granting the Board discretion to effect one or more reverse stock splits on Class A Common Stock at a ratio between 1-for-5 and 1-for-25. The authority must be exercised prior to or on December 31, 2026. This action is typically taken to address Nasdaq minimum bid price compliance requirements. Envoy Medical develops and sells medical devices for the treatment of hearing loss.